Body fat and increased risk of cirrhosis

BMJ (Online)

Volumn 340, Issue 7747, 2010, Pages 606-

  Byrne, Christopher D ^a   Wild, S H ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FAT; BODY MASS; DISEASE ASSOCIATION; EDITORIAL; HUMAN; LIVER CIRRHOSIS; OBESITY; PRIORITY JOURNAL; RISK FACTOR;

ADIPOSE TISSUE; ADULT; AGED; BODY MASS INDEX; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OBESITY; RISK FACTORS;

EID: 77949698681     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c774     Document Type: Editorial

References (12)

1. National Institute for Health and Clinical Excellence. Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children. 2006. www.nice.org.uk/CG43.
2. National Institutes for Health. Obesity. 2009. http://health.nih.gov/ topic/Obesity.
3. Troiano RP, Frongillo EA, Jr, Sobal J, Levitsky DA. The relationship between body weight and mortality: a quantitative analysis of combined information from existing studies. Int J Obes Relat Metab Disord 1996;20:63-75.[Web of Science][Medline]
4. NHS Information Centre. Statistics on obesity, physical activity and diet, England February 2009. 2009. www.ic.nhs.uk/statistics-and-data- collections/health-and-lifestyles/obesity/statistics-on-obesity-physical- activity-and-diet:-england-february-2009.
5. Liu B, Balkwill A, Reeves G, Beral V; on behalf of the Million Women Study Collaborators. Body mass index and risk of liver cirrhosis in middle aged women in UK: prospective study. BMJ 2010;340:c912. [Abstract/Free Full Text]
6. Hart CL, Morrison DS, Batty GD, Mitchell RJ, Davey Smith G. Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ 2010;340:c1240.[Abstract/Free Full Text]
7. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.[Abstract]
8. Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44:865-73.[CrossRef][Web of Science][Medline]
9. Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH. Metabolic disturbances in non-alcoholic fatty liver disease. Clin Sci(Lond) 2009;116:539-64.[CrossRef][Medline]
10. Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007;45:846-54. [CrossRef][Web of Science][Medline]
11. Ahmed MH, Byrne CD. Current treatment of non-alcoholic fatty liver disease. Diabetes Obes Metab 2009;11:188-95.[CrossRef][Web of Science][Medline]
12. Bromley C, Chaudhury M, Craig R, Deverill C, Erens B, Fuller E, et al. The Scottish health survey 2003. Scottish Government. www.scotland.gov.uk/ Publications/2005/11/25145024/50251.